Cardinal Health Inc. recalls cathflo activase (ALTEPLASE) 2 mg Rx Only NDC 50242-041-64 Genentech
Recalled June 2, 2021 · FDA recall D-0476-2021 · Cardinal Health
Hazard
CGMP Deviations: Intermittent exposure to temperature excursion during storage. · FDA Class II
Units
1473 vials
Sold at
FL, GA, SC
Description
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Product
cathflo activase (ALTEPLASE) 2 mg Rx Only NDC 50242-041-64 Genentech
Manufacturer(s)
Cardinal Health Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →